Concr was chosen as one of the 101 fastest-growing biotech companies based in Cambridgeshire by Best Startup London.
The list recognises a select few out of 100,000 UK-based startups and over 500,000 individuals holding key positions in these companies. The organisations showcased on this year's list are selected based on:
Concr co-founders Matthew Foster, Dr Matthew Griffiths and Dr Uzma Asghar were all featured in the article that also listed other notable high-performing biotech companies and leading figures from the thriving Cambridge life sciences ecosystem.
Concr CEO, Matthew Foster, commented: “As an early-stage biotech company, it is easy to be caught up in the technological rush. However, we could not do this without our world-class team — from astrophysics to oncology and everything in between.
This award is a timely recognition of our success as individuals and a highly multidisciplinary group that is pushing the boundaries of precision medicine. I can speak for the team in saying that we all look forward to seeing where the journey will lead us, and what impact we are going to make together!”
Despite the disruption caused by the COVID-19 pandemic and accompanying difficulties, throughout 2021, Concr continued to validate its technical capabilities, thanks to a growing number of partners who share its vision. This year Concr is delighted to launch its platform – Nightingale – to enable translational cancer researchers to access its advanced analytics directly.